USANA Health Sciences Inc (USNA)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 748,193 671,308 631,419 629,275 632,757 601,148 602,680 605,533 596,549 556,063 557,959 572,919 577,740 578,946 591,449 584,512 640,887 577,532 512,151 473,750
Total stockholders’ equity US$ in thousands 532,109 533,087 512,208 499,988 497,202 470,394 468,824 455,354 434,472 411,099 403,681 389,946 395,124 399,079 418,623 402,777 441,650 389,117 349,076 317,608
Financial leverage ratio 1.41 1.26 1.23 1.26 1.27 1.28 1.29 1.33 1.37 1.35 1.38 1.47 1.46 1.45 1.41 1.45 1.45 1.48 1.47 1.49

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $748,193K ÷ $532,109K
= 1.41

The financial leverage ratio of USANA Health Sciences Inc has shown a gradual decline from 1.49 as of March 31, 2020, to 1.41 as of June 30, 2021. This indicates that the company's reliance on debt to finance its operations has been decreasing over this period. However, there was a slight increase in the financial leverage ratio to 1.46 as of December 31, 2021, before it started decreasing again. The ratio reached its lowest point at 1.26 as of June 30, 2024, suggesting a stronger equity position relative to debt at that time. This trend indicates a potential improvement in the company's financial stability and risk management as it reduced its debt levels compared to equity.